The Biden administration is coordinating with Covid-19 vaccine manufacturers to develop contingency plans in the event future coronavirus vaccines need to be modified, including to fight the Omicron variant, the White House’s Covid-19 response coordinator said Tuesday.
Administration working with vaccine manufacturers to 'develop contingency plans' amid new variant
